About 30% of cases of the autosomal recessive immunodeficiency disorder hemophagocytic lymphohistiocytosis are believed to be caused by inactivating mutations of the perforin gene. We expressed perforin in rat basophil leukemia cells to define the basis of perforin dysfunction associated with two mutations, R225W and G429E, inherited by a compound heterozygote patient. Whereas RBL cells expressing wild-type perforin (67 kD) efficiently killed Jurkat target cells to which they were conjugated, the substitution to tryptophan at position 225 resulted in expression of a truncated (∼45 kD) form of the protein, complete loss of cytotoxicity, and failure to traffic to rat basophil leukemia secretory granules. By contrast, G429E perforin was correctly processed, stored, and released, but the rat basophil leukemia cells possessed reduced cytotoxicity. The defective function of G429E perforin mapped downstream of exocytosis and was due to its reduced ability to bind lipid membranes in a calcium-dependent manner. This study elucidates the cellular basis for perforin dysfunctions in hemophagocytic lymphohistiocytosis and provides the means for studying structure–function relationships for lymphocyte perforin.
Skip Nav Destination
Article navigation
20 September 2004
Brief Definitive Report|
September 13 2004
The Functional Basis for Hemophagocytic Lymphohistiocytosis in a Patient with Co-inherited Missense Mutations in the Perforin (PFN1) Gene
Ilia Voskoboinik,
Ilia Voskoboinik
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Search for other works by this author on:
Marie-Claude Thia,
Marie-Claude Thia
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Search for other works by this author on:
Annette De Bono,
Annette De Bono
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Search for other works by this author on:
Kylie Browne,
Kylie Browne
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Search for other works by this author on:
Erika Cretney,
Erika Cretney
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Search for other works by this author on:
Jacob T. Jackson,
Jacob T. Jackson
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Search for other works by this author on:
Phillip K. Darcy,
Phillip K. Darcy
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Search for other works by this author on:
Stephen M. Jane,
Stephen M. Jane
2Rotary Bone Marrow Transplant Unit, The Royal Melbourne Hospital, 3052, Victoria, Australia
Search for other works by this author on:
Mark J. Smyth,
Mark J. Smyth
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Search for other works by this author on:
Joseph A. Trapani
Joseph A. Trapani
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Search for other works by this author on:
Ilia Voskoboinik
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Marie-Claude Thia
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Annette De Bono
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Kylie Browne
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Erika Cretney
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Jacob T. Jackson
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Phillip K. Darcy
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Stephen M. Jane
2Rotary Bone Marrow Transplant Unit, The Royal Melbourne Hospital, 3052, Victoria, Australia
Mark J. Smyth
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Joseph A. Trapani
1Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
Address correspondence to Joseph A. Trapani, Cancer Immunology Program, Research Division, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St., 8006, Australia. Phone: 61-3-9656-3726; Fax: 61-3-9656-1411; email: [email protected]
I. Voskoboinik and M.-C. Thia contributed equally to this work.
Received:
April 20 2004
Accepted:
July 15 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 200 (6): 811–816.
Article history
Received:
April 20 2004
Accepted:
July 15 2004
Citation
Ilia Voskoboinik, Marie-Claude Thia, Annette De Bono, Kylie Browne, Erika Cretney, Jacob T. Jackson, Phillip K. Darcy, Stephen M. Jane, Mark J. Smyth, Joseph A. Trapani; The Functional Basis for Hemophagocytic Lymphohistiocytosis in a Patient with Co-inherited Missense Mutations in the Perforin (PFN1) Gene . J Exp Med 20 September 2004; 200 (6): 811–816. doi: https://doi.org/10.1084/jem.20040776
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement